NEUMORA THERAPEUTICS INC (NMRA) Top Institutional Shareholders
NEUMORA THERAPEUTICS INC (NMRA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $135.17M in NMRA holdings during the latest filing period.
Siren, L.L.C. is currently the largest disclosed institutional shareholder of NMRA tracked by InsiderSet, reporting ownership valued at approximately $16.57M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $13.00M, representing an estimated loss of -21.54% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 61% of the total disclosed NMRA value among the investors covered in this analysis. Major shareholders include Siren, L.L.C., Softbank Group Corp., Perceptive Advisors Llc, and several other long-term asset managers with concentrated positions in NEUMORA THERAPEUTICS INC (NMRA).
This page ranks the largest institutional NMRA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
111
Total Reported Value
$135.17M
Largest Holder
Siren, L.L.C.
Largest Position
$16.57M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
124
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Siren, L.L.C. | 0.46% | 8,497,822 | $16,570,753 | $13,001,668 | -$3,569,085 | -21.54% | |
| Softbank Group Corp. | 0.10% | 6,090,301 | $11,876,087 | $9,318,161 | -$2,557,926 | -21.54% | |
| Perceptive Advisors Llc | 0.20% | 5,104,097 | $9,952,989 | $7,809,268 | -$2,143,721 | -21.54% | |
| Mic Capital Management Uk Llp | 2.47% | 4,460,700 | $8,698,365 | $6,824,871 | -$1,873,494 | -21.54% | |
| Vanguard Capital Management Llc | 0.00% | 3,891,893 | $7,589,191 | $5,954,596 | -$1,634,595 | -21.54% | |
| Fmr Llc | 0.00% | 3,498,658 | $6,822,383 | $5,352,947 | -$1,469,436 | -21.54% | |
| Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust | 0.08% | 3,309,123 | $6,452,790 | $5,062,958 | -$1,389,832 | -21.54% | |
| Millennium Management Llc | 0.00% | 2,754,854 | $5,371,965 | $4,214,927 | -$1,157,038 | -21.54% | |
| Iconiq Capital, Llc | 0.11% | 2,559,090 | $4,990,226 | $3,915,408 | -$1,074,818 | -21.54% | |
| Lunate Capital Ltd | 3.44% | 2,124,143 | $4,142,079 | $3,249,939 | -$892,140 | -21.54% | |
| Blackrock, Inc. | 0.00% | 2,054,316 | $4,005,917 | $3,143,103 | -$862,814 | -21.54% | |
| Two Sigma Investments, Lp | 0.00% | 2,036,692 | $3,971,549 | $3,116,139 | -$855,410 | -21.54% | |
| Johnson & Johnson | 0.55% | 1,849,445 | $3,606,418 | $2,829,651 | -$776,767 | -21.54% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 1,388,998 | $2,708,546 | $2,125,167 | -$583,379 | -21.54% |
| Ikarian Capital, Llc | 0.36% | 1,278,408 | $2,492,896 | $1,955,964 | -$536,932 | -21.54% | |
| Susquehanna International Group, Llp | 0.00% | 1,240,241 | $2,418,470 | $1,897,569 | -$520,901 | -21.54% | |
| Marshall Wace, Llp | 0.00% | 1,195,310 | $2,330,856 | $1,828,824 | -$502,032 | -21.54% | |
| Geode Capital Management, Llc | 0.00% | 1,086,865 | $2,120,406 | $1,662,903 | -$457,503 | -21.58% | |
| Adage Capital Partners Gp, L.L.C. | 0.00% | 1,000,000 | $1,950,000 | $1,530,000 | -$420,000 | -21.54% | |
| Silverarc Capital Management, Llc | 0.19% | 818,156 | $1,595,404 | $1,251,779 | -$343,625 | -21.54% | |
| Tudor Investment Corp Et Al | 0.01% | 771,418 | $1,504,265 | $1,180,270 | -$323,995 | -21.54% | |
| Jane Street Group, Llc | 0.00% | 747,665 | $1,457,947 | $1,143,927 | -$314,020 | -21.54% | |
| Alphacore Capital Llc | 0.03% | 638,784 | $1,245,629 | $977,340 | -$268,289 | -21.54% | |
| Point72 Asset Management, L.P. | 0.00% | 602,403 | $1,174,686 | $921,677 | -$253,009 | -21.54% | |
| Goldman Sachs Group Inc | 0.00% | 568,280 | $1,108,146 | $869,468 | -$238,678 | -21.54% | |
| Vanguard Fiduciary Trust Co | 0.00% | 535,033 | $1,043,314 | $818,600 | -$224,714 | -21.54% | |
| Charles Schwab Investment Management Inc | 0.00% | 516,182 | $1,006,555 | $789,758 | -$216,797 | -21.54% | |
| Franklin Resources Inc | 0.00% | 511,084 | $996,614 | $781,959 | -$214,655 | -21.54% | |
| Morgan Stanley | 0.00% | 503,819 | $982,448 | $770,843 | -$211,605 | -21.54% | |
| Tang Capital Management Llc | 0.04% | 439,878 | $857,762 | $673,013 | -$184,749 | -21.54% | |
| Caption Management, Llc | 0.04% | 412,201 | $803,792 | $630,668 | -$173,124 | -21.54% | |
| State Street Corp | 0.00% | 398,719 | $777,502 | $610,040 | -$167,462 | -21.54% | |
| Dimensional Fund Advisors Lp | 0.00% | 354,850 | $691,795 | $542,921 | -$148,875 | -21.52% | |
| Citadel Advisors Llc | 0.00% | 343,586 | $669,993 | $525,687 | -$144,306 | -21.54% | |
| Boothbay Fund Management, Llc | 0.02% | 335,267 | $653,771 | $512,959 | -$140,812 | -21.54% | |
| Federated Hermes, Inc. | 0.00% | 314,119 | $612,532 | $480,602 | -$131,930 | -21.54% | |
| Jacobs Levy Equity Management, Inc | 0.00% | 273,870 | $534,046 | $419,021 | -$115,025 | -21.54% | |
| Cerity Partners Llc | 0.00% | 260,391 | $507,763 | $398,398 | -$109,365 | -21.54% | |
| Bridgeway Capital Management, Llc | 0.01% | 225,000 | $438,750 | $344,250 | -$94,500 | -21.54% | |
| Xtx Topco Ltd | 0.01% | 221,848 | $432,604 | $339,427 | -$93,177 | -21.54% | |
| Invesco Ltd. | 0.00% | 205,929 | $401,562 | $315,071 | -$86,491 | -21.54% | |
| Qube Research & Technologies Ltd | 0.00% | 197,363 | $384,858 | $301,965 | -$82,893 | -21.54% | |
| Northern Trust Corp | 0.00% | 196,881 | $383,918 | $301,228 | -$82,690 | -21.54% | |
| Exoduspoint Capital Management, Lp | 0.00% | 191,677 | $373,770 | $293,266 | -$80,504 | -21.54% | |
| Vanguard Portfolio Management Llc | 0.00% | 184,836 | $360,430 | $282,799 | -$77,631 | -21.54% | |
| Bank Of America Corp | 0.00% | 176,927 | $345,008 | $270,698 | -$74,310 | -21.54% | |
| Addis & Hill, Inc | 0.19% | 163,386 | $318,603 | $249,981 | -$68,622 | -21.54% | |
| Susquehanna Portfolio Strategies, Llc | 0.00% | 160,319 | $312,622 | $245,288 | -$67,334 | -21.54% | |
| Maniro Ltd | 0.09% | 158,231 | $308,551 | $242,093 | -$66,458 | -21.54% | |
| Squarepoint Ops Llc | 0.00% | 156,214 | $304,617 | $239,007 | -$65,610 | -21.54% |
Frequently asked questions about NMRA
Who owns the most NMRA stock?
The largest holders of NMRA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NEUMORA THERAPEUTICS INC (NMRA).
Is NMRA widely held by superinvestors?
Many widely followed stocks like NMRA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NMRA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.